What providers need to know about the Inflation Reduction Act

Beginning April 1, 2023, Humana-covered patients may pay less for certain drugs covered by Medicare Part B benefits based on a new and lower “coinsurance” amount (their share of the prescription cost after they meet their deductible). The list of eligible drugs will be updated every 3 months. Any reduction in patients’ out-of-pocket cost for eligible drugs will be made when they pay for their prescriptions at the pharmacy. For patients who receive Medicare Part B drugs at a location other than a pharmacy, Humana will ensure patient cost share is adjusted where appropriate. For patients who receive these Part B drugs at these locations, Humana will mail a refund where appropriate until systems are fully updated to allow for adjustment as part of normal claim processing.

Please note these changes do not apply to Medicare Part D prescription drug coverage.

View the current list of eligible drugs, PDF.

This list will be updated every 3 months.

Starting July 1, 2023, if Humana-covered patients take insulin that is covered by their Medicare Part B benefits, their plan deductible will no longer apply to their Medicare Part B insulin prescription. Patients will pay no more than $35 for a 1-month (30-day) supply of a Part B-covered insulin. This cost limit applies to insulin dispensed through a pump or Medicare-covered durable medical equipment.